Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

CHRISTINE M SMITH

Allopathic & Osteopathic Physicians Family Medicine

NPI
1376520387
CMS profile
152596
Location
BATON ROUGE, LA

General Payments · PY2020–2024

$104,679.94

  • Reported across 63 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$48,072.46

27 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $47,440.00 23
Travel and Lodging $622.16 3
Food and Beverage $10.30 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Takeda Pharmaceuticals U.S.A., Inc. $48,072.46 27

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2020 $490.14 2
PY2021 $12,530.66 9
PY2022 $26,083.98 14
PY2023 $17,502.70 11
PY2024 $48,072.46 27

Payment records · PY2024 (27)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Takeda Pharmaceuticals U.S.A., Inc. $2,180.00 01/17/2024 Consulting Fee Undisputed 01/23/2026 1137678337 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,180.00 02/14/2024 Consulting Fee Undisputed 01/23/2026 1137678339 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,000.00 02/26/2024 Consulting Fee Undisputed 01/23/2026 1137678341 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,180.00 03/11/2024 Consulting Fee Undisputed 01/23/2026 1137678343 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,180.00 04/17/2024 Consulting Fee Undisputed 01/23/2026 1137678345 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,090.00 05/06/2024 Consulting Fee Undisputed 01/23/2026 1137678347 CMS
Takeda Pharmaceuticals U.S.A., Inc. $189.21 05/06/2024 Travel and Lodging Undisputed 01/23/2026 1137678349 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,180.00 05/10/2024 Consulting Fee Undisputed 01/23/2026 1137678351 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,180.00 06/10/2024 Consulting Fee Undisputed 01/23/2026 1137678353 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,180.00 06/10/2024 Consulting Fee Undisputed 01/23/2026 1137678355 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,090.00 06/17/2024 Consulting Fee Undisputed 01/23/2026 1137678357 CMS
Takeda Pharmaceuticals U.S.A., Inc. $94.60 06/17/2024 Travel and Lodging Undisputed 01/23/2026 1137678359 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,180.00 07/12/2024 Consulting Fee Undisputed 01/23/2026 1137678361 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,180.00 07/12/2024 Consulting Fee Undisputed 01/23/2026 1137678363 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,180.00 08/09/2024 Consulting Fee Undisputed 01/23/2026 1137678365 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,180.00 08/09/2024 Consulting Fee Undisputed 01/23/2026 1137678367 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,180.00 09/11/2024 Consulting Fee Undisputed 01/23/2026 1137678369 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,180.00 09/11/2024 Consulting Fee Undisputed 01/23/2026 1137678371 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,180.00 10/09/2024 Consulting Fee Undisputed 01/23/2026 1137678373 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,180.00 10/09/2024 Consulting Fee Undisputed 01/23/2026 1137678375 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,180.00 11/13/2024 Consulting Fee Undisputed 01/23/2026 1137678377 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,180.00 11/13/2024 Consulting Fee Undisputed 01/23/2026 1137678379 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,200.00 12/04/2024 Consulting Fee Undisputed 01/23/2026 1137678381 CMS
Takeda Pharmaceuticals U.S.A., Inc. $338.35 12/04/2024 Travel and Lodging Undisputed 01/23/2026 1137678383 CMS
Takeda Pharmaceuticals U.S.A., Inc. $10.30 12/04/2024 Food and Beverage Undisputed 01/23/2026 1137678385 CMS
Takeda Pharmaceuticals U.S.A., Inc. $3,000.00 12/09/2024 Consulting Fee Undisputed 01/23/2026 1137678387 CMS
Takeda Pharmaceuticals U.S.A., Inc. $3,000.00 12/09/2024 Consulting Fee Undisputed 01/23/2026 1137678389 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.